AI predicts stomach cancer response to chemo before surgery
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study tests whether an AI tool can predict how well stomach cancer responds to chemotherapy before surgery. It uses CT scans and biopsy images taken before treatment starts to see if the AI can help guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have advanced gastric cancer (stage II or higher) that has been confirmed by a biopsy.
- You have not had any cancer treatment (like chemo, radiation, or surgery) for this stomach cancer before starting chemo.
- You have received the standard type of chemo for stomach cancer, and your doctors have kept records of your treatment.
- You had a CT scan and a biopsy of your tumor within one month before starting chemo, and the images are clear.
- You do not have any other active cancer besides this stomach cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a computer-based model that uses CT scans, endoscopic images, and biopsy tissue to predict how well stomach cancer will respond to chemotherapy given before surgery. The goal is to help doctors choose the best treatment for each patient.
This study uses artificial intelligence to analyze your CT scan and predict whether stomach cancer has spread to lymph nodes behind your belly. The goal is to help doctors decide if you need more extensive surgery.
This study uses artificial intelligence to help doctors decide whether patients who bleed after stomach cancer surgery need another operation. Researchers will review medical records and test an AI system to improve decision-making for this serious complication.
This study looks for ways to predict whether neoadjuvant chemotherapy (chemo given before surgery) will work well in people with locally advanced stomach cancer. It may help doctors choose the best treatment plan sooner based on your test results.
This study uses a special artificial intelligence (AI) program to help doctors spot stomach cancer during an upper endoscopy (a camera test of the stomach). It is for people 60 and older who are already scheduled for this test because they have a higher risk of stomach cancer.
This trial uses artificial intelligence to analyze CT scans, blood, and tumor tissue to predict how well your cancer will respond to chemotherapy and immunotherapy before surgery. It aims to personalize treatment for locally advanced stomach or gastroesophageal junction cancer.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.